Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Zander

Showing results (111-120 of 206) with videos related to

Pageof 21
Sort By:
Oncoimmunology|May 10, 2019
The expression of the immune checkpoint regulator VISTA correlates with improved overall survival in pT1/2 tumor stages in esophageal adenocarcinomaHeike Loeser, Max Kraemer, Florian Gebauer, et al.
Journal of Cancer Research and Clinical Oncology|November 23, 2022
FGFR2-amplified tumor clones are markedly heterogeneously distributed in carcinomas of the upper gastrointestinal tractJan Albin, Luca Fahrig, Janna Siemanowski, et al.
Journal of Cancer Research and Clinical Oncology|December 10, 2020
GATA binding protein 6 (GATA6) is co-amplified with PIK3CA in patients with esophageal adenocarcinoma and is linked to neoadjuvant therapyPatrick Sven Plum, Heike Löser, Thomas Zander, et al.
Soft Matter|September 5, 2019
Influence of high hydrostatic pressure on solid supported DPPC bilayers with hyaluronan in the presence of Ca<sup>2+</sup> ionsThomas Zander, D C Florian Wieland, Akanksha Raj, et al.
Scientific Reports|October 16, 2023
Tumour area infiltration and cell count in endoscopic biopsies of therapy-naive upper GI tract carcinomas by QuPath analysis: implications for predictive biomarker testingAndreas H Scheel, Hannah Lamberty, Yuri Tolkach, et al.
BMC Cancer|January 8, 2020
Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinomaSimon Schallenberg, Julian Bork, Ahlem Essakly, et al.
Journal of Colloid and Interface Science|January 18, 2015
The effect of temperature on supported dipalmitoylphosphatidylcholine (DPPC) bilayers: structure and lubrication performanceMin Wang, Thomas Zander, Xiaoyan Liu, et al.
Journal of Cancer Research and Clinical Oncology|June 28, 2020
Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinomaFlorian Gebauer, Max Krämer, Christiane Bruns, et al.
International Journal of Cancer|July 22, 2025
Adjuvant FLOT provides survival benefit for oesophagogastric junction and gastric adenocarcinoma patients with low tumour regression after neoadjuvant chemotherapyMax Kraemer, Naita M Wirsik, Hakan Alakus, et al.
Journal of Cancer Research and Clinical Oncology|March 30, 2022
A phase 1 study of IDH305 in patients with IDH1<sup>R132</sup>-mutant acute myeloid leukemia or myelodysplastic syndromeCourtney D DiNardo, Andreas Hochhaus, Mark G Frattini, et al.
Pageof 21

Showing results (111-120 of 206) with videos related to

Sort By:
Pageof 21
Oncoimmunology|May 10, 2019
The expression of the immune checkpoint regulator VISTA correlates with improved overall survival in pT1/2 tumor stages in esophageal adenocarcinomaHeike Loeser, Max Kraemer, Florian Gebauer, et al.
Journal of Cancer Research and Clinical Oncology|November 23, 2022
FGFR2-amplified tumor clones are markedly heterogeneously distributed in carcinomas of the upper gastrointestinal tractJan Albin, Luca Fahrig, Janna Siemanowski, et al.
Journal of Cancer Research and Clinical Oncology|December 10, 2020
GATA binding protein 6 (GATA6) is co-amplified with PIK3CA in patients with esophageal adenocarcinoma and is linked to neoadjuvant therapyPatrick Sven Plum, Heike Löser, Thomas Zander, et al.
Soft Matter|September 5, 2019
Influence of high hydrostatic pressure on solid supported DPPC bilayers with hyaluronan in the presence of Ca<sup>2+</sup> ionsThomas Zander, D C Florian Wieland, Akanksha Raj, et al.
Scientific Reports|October 16, 2023
Tumour area infiltration and cell count in endoscopic biopsies of therapy-naive upper GI tract carcinomas by QuPath analysis: implications for predictive biomarker testingAndreas H Scheel, Hannah Lamberty, Yuri Tolkach, et al.
BMC Cancer|January 8, 2020
Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinomaSimon Schallenberg, Julian Bork, Ahlem Essakly, et al.
Journal of Colloid and Interface Science|January 18, 2015
The effect of temperature on supported dipalmitoylphosphatidylcholine (DPPC) bilayers: structure and lubrication performanceMin Wang, Thomas Zander, Xiaoyan Liu, et al.
Journal of Cancer Research and Clinical Oncology|June 28, 2020
Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinomaFlorian Gebauer, Max Krämer, Christiane Bruns, et al.
International Journal of Cancer|July 22, 2025
Adjuvant FLOT provides survival benefit for oesophagogastric junction and gastric adenocarcinoma patients with low tumour regression after neoadjuvant chemotherapyMax Kraemer, Naita M Wirsik, Hakan Alakus, et al.
Journal of Cancer Research and Clinical Oncology|March 30, 2022
A phase 1 study of IDH305 in patients with IDH1<sup>R132</sup>-mutant acute myeloid leukemia or myelodysplastic syndromeCourtney D DiNardo, Andreas Hochhaus, Mark G Frattini, et al.
Pageof 21